Serum levels of lamotrigine during delivery in mothers and their infants

被引:19
|
作者
Kacirova, Ivana [1 ]
Grundmann, Milan
Brozmanova, Hana
机构
[1] Univ Ostrava, Univ Hosp Ostrava, Fac Med, Dept Clin Pharmacol, CZ-70852 Ostrava, Czech Republic
关键词
Lamotrigine; Therapeutic drug monitoring; Epilepsy; Delivery; ANTIEPILEPTIC DRUGS; HUMAN PLACENTA; PREGNANCY; PHARMACOKINETICS; LOCALIZATION; EXPRESSION; CLEARANCE; LACTATION;
D O I
10.1016/j.eplepsyres.2010.07.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We followed up lamotrigine transport through the placenta and analyzed maternal and umibilical cord concentrations, its ratio and maternal lamotrigine clearance in monotherapy and in combinations. Methods: Maternal and umbilical cord concentrations were analyzed during delivery in a cohort of 63 women between 2001 and 2009. The request forms for routine therapeutic drug monitoring were used as the data source. Maternal concentrations were used for the estimation of apparent oral clearance and paired infant and maternal concentrations for estimation of the infant (umibilical cord)/maternal serum concentration ratio. Results: The lamotrigine infant/maternal serum concentration ratio ranged in monotherapy from 0.40 to 1.38 (median 0.91). The ratio in monotherapy showed a possible distribution to two subgroups. Concomitant administration of valproic acid significantly increased both maternal and infant lamotrigine concentrations and significantly decreased lamotrigine clearance by about 65%. Co-medication with carbamazepine increased lamotrigine clearance non-significantly. Highly significant correlations were found between maternal and umbilical cord lamotrigine concentrations, both in monotherapy and in the lamotrigine + valproic acid combination. Infant concentrations of valproic acid were found to be about 30% higher and infant concentrations of carbamazepine were found to be about 20% lower than maternal concentrations. Conclusions: Our data from the large cohort showed the interindividual variability of umbilical cord/maternal serum concentration ratio in lamotrigine monotherapy caused probably by the different activity of the placental lamotrigine metabolizing enzymes UGT1A4 and 2B7 associated with genetic polymorphism. The potential teratogenic effect of lamotrigine combination with valproic acid could be associated with the higher lamotrigine and valproic acid concentrations in the fetus. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
  • [41] The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy
    Gulcebi, Medine Idrizoglu
    Ozkaynakci, Aydan
    Goren, Mehmet Zafer
    Aker, Rezzan Gulhan
    Ozkara, Cigdem
    Onat, Filiz Yilmaz
    EPILEPSY RESEARCH, 2011, 95 (1-2) : 1 - 8
  • [42] Determination of lamotrigine in human serum by high-performance liquid chromatography tandem mass spectrometry
    Lee, Woonhyoung
    Kim, Jeong-Ho
    Kim, Hyon-Suk
    Kwon, Oh Hun
    Lee, Byung In
    Heo, Kyoung
    NEUROLOGICAL SCIENCES, 2010, 31 (06) : 717 - 720
  • [43] Is breast-feeding of infants advisable for epileptic mothers taking antiepileptic drugs?
    Chen, Lei
    Liu, Fang
    Yoshida, Shuichi
    Kaneko, Sunao
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 64 (05) : 460 - 468
  • [44] Can physiologic menstrual cycle change serum lamotrigine concentration?
    Asadollahi, Marjan
    Ramezani, Mahtab
    Karimialavijeh, Ehsan
    Tavakolian, Mehrnaz
    Ramezani, Maryam
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 33 : 35 - 37
  • [45] The risks associated with the use of lamotrigine during pregnancy
    Kong, Lingli
    Zhou, Tiantian
    Wang, Bailing
    Gao, Zhenbo
    Wang, Chunxia
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2018, 22 (01) : 2 - 5
  • [46] Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants
    Nicole Bosshard
    Astrid Zbinden
    Klara Kristin Eriksson
    Frauke Förger
    Rheumatology and Therapy, 2021, 8 : 1043 - 1048
  • [47] Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants
    Bosshard, Nicole
    Zbinden, Astrid
    Eriksson, Klara Kristin
    Forger, Frauke
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 1043 - 1048
  • [48] Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy
    Wang, Qiuning
    Liang, Min
    Dong, Yang
    Yun, Wenting
    Qiu, Feng
    Zhao, Limei
    Guo, Yingjie
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (03) : 209 - 213
  • [49] Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity
    Cheng, Yong
    Zhu, Xuemei
    Linghu, Dandan
    Xu, Yongsheng
    Liang, Jianhong
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [50] Lamotrigine serum concentration-to-dose ratio: Influence of age and concomitant antiepileptic drugs and dosage implications
    Armijo, JA
    Bravo, J
    Cuadrado, A
    Herranz, JL
    THERAPEUTIC DRUG MONITORING, 1999, 21 (02) : 182 - 190